Maria Carvalho briefly discusses and provides 8 of the published, peer-reviewed stability studies of compounded medications with PCCA's SuspendIt. These studies were conducted by the researchers at Xavier University of Louisiana.

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part two in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines. This particular section focuses on USP <797>.

PCCA's Director of Formulation Development Melissa Merrell Rhoads, PharmD, provides part one in a set of posts detailing the upcoming changes to our formulas based upon the new USP guidelines.

Want some clarity on USP <797> and USP <800> updates? Our August updates to PCCA Play are designed to do just that with a free presentation from PCCA Education and Training Manager Jerra Banwarth, RPh, FIACP and Eagle President Ross Caputo, PhD. In another video, subscribers to PCCA Play can watch Eagle Vice President of Operations Megan Jeffrey Liotta, MS, discuss USP <797> regulation updates.

Dylan Herr, RA/QA Development Manager at Eagle, understands that the revised USP <797> chapter for sterile compounding makes significant revisions to the old chapter. In this latest article, Dyan is happy to provide you with an overview of those changes and strategies for implementing them.

The only thing that stays the same is that everything changes. This is true even when it comes to nonsterile compounding and USP <795>. PCCA Clinical Compounding Pharmacist Matt Martin, PharmD, addresses notable changes of the new USP guidelines and provides some considerations regarding implementation.

"Do you have questions about what it means to be compliant with various parts of USP <800>?" "Do you have the equipment you need?" Matt Martin, PharmD, of PCCA's Clinical Services provides an in-depth checklist of considerations you need to have while trying to navigate USP <800>.

PCCA partnered with a tremendous company, The Nicos Group. Here's why we did and why we think they would make a great partner for you as well.

PCCA is proud to announce its updated USP<800> educational page. This new, streamlined experience offers answers to the questions PCCA has received regarding the new guidelines set for December 1, 2019.

Jeff Gloyer is an engineer I with Eagle. He has experience working with multidisciplinary teams to implement the engineering design process. Here he discusses considerations that compounding pharmacies need to take in order to ensure they are USP <797> and <800> compliant.